ZAP Surgical Systems has announced the completion of the first patient brain tumour treatments at Dongguk University Ilsan Hospital in South Korea using the ZAP-X Gyroscopic Radiosurgery platform.
This marks the second installation of the ZAP-X system in Korea.
The ZAP-X platform is a medical device designed to provide non-invasive and painless stereotactic radiosurgery (SRS) for treating various brain conditions.
Related: PatchClamp and PCS to develop new dural repair graft system
SRS is a preferred alternative to traditional surgery, offering outcomes that are often equivalent or superior, with the added benefit of minimal patient downtime.
The neurosurgery department at Dongguk University Ilsan Hospital will now independently conduct cranial SRS treatments using the ZAP-X system.
Dongguk University Ilsan Hospital neurosurgery professor Dr Seung-yeob Yang said: “The ZAP-X system represents a meaningful advancement in our ability to treat primary and metastatic brain tumours, as well as functional disorders such as trigeminal neuralgia.
“Its precision and non-invasive nature allow us to provide our patients with the best possible care while minimizing side effects and patient downtime.
“Together with superior technical capabilities, the ZAP-X platform offered significant advantages over traditional radiation delivery systems. Also, ZAP-X eliminated the need to construct a shielded radiation bunker and allowed for easy installation in our existing outpatient Neurosurgery department.”
Tailored specifically for head, cranial, and neck applications, the ZAP-X system features a gyroscopic design that allows for precise delivery of high-dose radiation from multiple angles, focusing on the tumour while sparing healthy brain tissue.
This approach is critical for preserving patient cognitive function.
Additionally, the system’s vault-free and cobalt-free design simplifies installation and maintenance, as it does not require shielded rooms or the handling of radioactive isotopes.
Last year, ZAP Surgical secured approval from China’s National Medical Products Administration for its ZAP-X platform.
